DGI:Opportunistische Infektionen/Zerebrale Toxoplasmose/Quellen: Difference between revisions

From Infektiopedia
imported>Bestem
No edit summary
imported>Bestem
No edit summary
 
Line 1: Line 1:
* <span style="color: black">https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Toxoplasmose.html;jsessionid=6F4003131E144DDB68FB03F9762455B6.internet082</span>


 
*Pleyer U, Gross U, Schlüter D, Wilking H, Seeber F. Toxoplasmosis in Germany. Dtsch Arztebl Int. 2019;116(25):435-444. doi:10.3238/arztebl.2019.0435
#<span style="color: black">https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Toxoplasmose.html;jsessionid=6F4003131E144DDB68FB03F9762455B6.internet082</span>
*Schmidt-Hieber M, Silling G, Schalk E, et al. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2016;27(7):1207-1225. doi:10.1093/annonc/mdw155
#Pleyer U, Gross U, Schlüter D, Wilking H, Seeber F. Toxoplasmosis in Germany. Dtsch Arztebl Int. 2019;116(25):435-444. doi:10.3238/arztebl.2019.0435
*Ullmann AJ, Schmidt-Hieber M, Bertz H, et al. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol. 2016;95(9):1435-1455. doi:10.1007/s00277-016-2711-1
#Schmidt-Hieber M, Silling G, Schalk E, et al. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2016;27(7):1207-1225. doi:10.1093/annonc/mdw155
*LL OI 2014-2.pdf. Accessed November 7, 2021. <nowiki>https://daignet.de/site-content/hiv-leitlinien/leitlinien-1/LL%20OI%202014-2.pdf</nowiki> <br />
#Ullmann AJ, Schmidt-Hieber M, Bertz H, et al. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol. 2016;95(9):1435-1455. doi:10.1007/s00277-016-2711-1
#LL OI 2014-2.pdf. Accessed November 7, 2021. <nowiki>https://daignet.de/site-content/hiv-leitlinien/leitlinien-1/LL%20OI%202014-2.pdf</nowiki> <br />

Latest revision as of 16:20, 30 November 2021

  • Pleyer U, Gross U, Schlüter D, Wilking H, Seeber F. Toxoplasmosis in Germany. Dtsch Arztebl Int. 2019;116(25):435-444. doi:10.3238/arztebl.2019.0435
  • Schmidt-Hieber M, Silling G, Schalk E, et al. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2016;27(7):1207-1225. doi:10.1093/annonc/mdw155
  • Ullmann AJ, Schmidt-Hieber M, Bertz H, et al. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol. 2016;95(9):1435-1455. doi:10.1007/s00277-016-2711-1
  • LL OI 2014-2.pdf. Accessed November 7, 2021. https://daignet.de/site-content/hiv-leitlinien/leitlinien-1/LL%20OI%202014-2.pdf
Retrieved from "https://wiki.cakele.iodatalabs.dev/index.php?title=DGI:Opportunistische_Infektionen/Zerebrale_Toxoplasmose/Quellen&oldid=3311"